Yilmaz, N. S. Et Al. 2022. A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response: a pilot study. JOURNAL OF NEURAL TRANSMISSION , no.12 , 1513-1526.

Yilmaz, N. S., Sen, B., KARADAĞ, R. F., ASLAN, S., EKMEKCİ ERTEK, İ., Bozkurt, A., ... ÇİÇEK, S.(2022). A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response: a pilot study. JOURNAL OF NEURAL TRANSMISSION , no.12, 1513-1526.

Yilmaz, NİYAZİ Et Al. "A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response: a pilot study," JOURNAL OF NEURAL TRANSMISSION , no.12, 1513-1526, 2022

Yilmaz, NİYAZİ S. Et Al. "A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response: a pilot study." JOURNAL OF NEURAL TRANSMISSION , no.12, pp.1513-1526, 2022

Yilmaz, N. S. Et Al. (2022) . "A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response: a pilot study." JOURNAL OF NEURAL TRANSMISSION , no.12, pp.1513-1526.

@article{article, author={NİYAZİ SAMET YILMAZ Et Al. }, title={A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response: a pilot study}, journal={JOURNAL OF NEURAL TRANSMISSION}, year=2022, pages={1513-1526} }